Morgan Stanley stands among the largest global financial institutions, with operations spanning investment banking, trading, wealth management, and investment management. Its quarterly updates provide a useful window into capital markets activity, corporate deal flow, and overall investor appetite. After several strong periods, the firm looked to sustain returns above 20% even as September market conditions softened trading volumes. For investors, the update helps assess whether the diversified model can continue expanding client assets and revenue amid elevated rates and geopolitical risks.
For the third quarter ended September 30, 2026, Morgan Stanley posted net revenue of $20.34 billion, up 12% from $18.22 billion a year earlier. Net income attributable to the firm increased 6.5% to $4.91 billion, resulting in diluted EPS of $3.03 compared with $2.80 in the prior-year quarter. Both figures topped LSEG consensus estimates of $19.95 billion and $2.91.
The Institutional Securities segment stood out, with net revenue advancing 18% to $10 billion. Equities trading revenue reached $5.8 billion, a 41% jump fueled by broad strength across products and regions, especially Asia. That result surpassed StreetAccount estimates by roughly $909 million. Advisory revenue climbed 30% to $887 million on higher completed M&A activity.
Those gains helped balance softer areas. Fixed income, currencies, and commodities trading revenue slipped 7% to $2.01 billion, while investment banking revenue rose just 2% to $2.16 billion. Wealth Management achieved record revenue of $9.1 billion and a 30.4% pre-tax margin. Investment Management revenue declined 12% to $1.5 billion, partly reflecting a reversal of accrued carried interest from a private fund. Return on tangible common equity came in at 22.6%. I also checked this using Tickeron’s AI Screener to compare the results with peers in the sector.
Even with the headline beat, Morgan Stanley shares fell about 2% in pre-market trading after the release. Analysts viewed the results as solid yet not exceptional, pointing to slower-than-expected improvement in several metrics. The fixed income shortfall and modest investment banking growth weighed on sentiment for some, against a backdrop of cautious market activity in September tied to rising energy prices and higher interest rates.
Going forward, attention will center on whether Morgan Stanley can turn its record client inflows into sustained revenue growth. The firm finished the quarter with roughly $10.5 trillion in total client assets across Wealth and Investment Management. Management anticipates a modest rise in net interest income in the fourth quarter, depending on rate movements and client behavior.
Capital markets activity remains an important variable. A busy IPO calendar has supported asset inflows, and the pace of deal completions will affect investment banking revenue. Fixed income outcomes will hinge on whether structured credit and commodities activity stabilizes. Expense trends and capital deployment also deserve monitoring. The firm repurchased $1.5 billion of common stock in the quarter and closed with a Common Equity Tier 1 capital ratio of 14.9%. How management balances technology investments, including AI and digital tools, with cost discipline and shareholder returns will influence results in coming quarters.
In my own research process, I frequently use Tickeron’s AI Screener to quickly filter financial-sector names and spot patterns or peers worth deeper review. It allows customizable scans across industries, market caps, technical indicators, and performance metrics, which helps surface ideas more efficiently while I cross-check with other data sources. The tool has become a regular part of how I organize sector comparisons without replacing fundamental analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
The 50-day moving average for MS moved below the 200-day moving average on November 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MS as a result. In 41 of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.
The Moving Average Convergence Divergence Histogram (MACD) for MS turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 24 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
The RSI Indicator entered the oversold zone -- be on the watch for MS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in 230 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 167 of 304 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 64 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.674) is normal, around the industry mean (3.143). P/E Ratio (14.515) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (1.702) is also within normal values, averaging (0.809). Dividend Yield (0.025) settles around the average of (8.975) among similar stocks. P/S Ratio (4.380) is also within normal values, averaging (17.075).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of diversified financial services including brokerage, investment management and venture capital services
Industry InvestmentBanksBrokers